Replicon MRNA: 3 Clinical Trials

Hide Studies Not Open or Pending

Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)

Condition(s):COVID-19; SARS-CoV-2Last Updated:May 25, 2023Active, not recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

Condition(s):SARS-CoV-2Last Updated:April 4, 2022Recruiting

Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C

Condition(s):Hepatitis CLast Updated:March 26, 2010Unknown status

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.